PDE7A/CRE Reporter - HEK293 Recombinant Cell Line

Catalog #
60413
$9,270 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PDE7A/CRE Reporter-HEK293 line contains the firefly luciferase gene under the control of CRE as well as a constitutive expression construct for human PDE7A (phosphodiesterase 7A, accession number NM_002603), both stably integrated into HEK293 cells. The luciferase expression level from the CRE reporter is used to monitor the activity of PDE7A in the cells.

Interested in screening and profiling inhibitors of PDE7A without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
PDE7, phosphodiesterase 7, CRE reporter, PDE7-A, PDE
Product Info
Storage and Usage
Citations
Host Cell Line
HEK293 cells
Species
Human
Supplied As
Each vial contains ~ X 106 cells in 1 ml of 10% DMSO.
Biological Activity
The cell line is validated for the induction of the expression of luciferase reporter by an inhibitor of PDE7A.
Genbank #
NM_002603
UniProt #
Q13946
Mycoplasma Testing
The cell line has been screened using the PCR-based VenorGeM Mycoplasma Detection kit (Sigma Aldrich) to confirm the absence of Mycoplasma species.
References

1. Malik, R. et al. (2008) Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Appl.               Microbiol. Biotechnol. 77 (5): 1167-1173.

2.  Fan Chung, K. (2006) Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol. 533(1-3):110-117.